EXHIBIT 12
3M COMPANY AND SUBSIDIARIES
CALCULATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Millions)
|
|
2007 |
|
2006 |
|
2005 |
|
2004 |
|
2003 |
|
|||||
EARNINGS |
|
|
|
|
|
|
|
|
|
|
|
|||||
Income before income taxes, minority interest, and cumulative effect of accounting change* |
|
$ |
6,115 |
|
$ |
5,625 |
|
$ |
4,828 |
|
$ |
4,303 |
|
$ |
3,448 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Add: |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Interest expense |
|
229 |
|
139 |
|
101 |
|
88 |
|
103 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Interest component of the ESOP benefit expense |
|
5 |
|
8 |
|
10 |
|
12 |
|
14 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Portion of rent under operating leases representative of the interest component |
|
70 |
|
70 |
|
64 |
|
60 |
|
53 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Less: |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Equity in undistributed income of 20-50% owned companies |
|
5 |
|
6 |
|
4 |
|
6 |
|
7 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
TOTAL EARNINGS AVAILABLE FOR FIXED CHARGES |
|
$ |
6,414 |
|
$ |
5,836 |
|
$ |
4,999 |
|
$ |
4,457 |
|
$ |
3,611 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
FIXED CHARGES |
|
|
|
|
|
|
|
|
|
|
|
|||||
Interest on debt |
|
235 |
|
138 |
|
94 |
|
78 |
|
93 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Interest component of the ESOP benefit expense |
|
5 |
|
8 |
|
10 |
|
12 |
|
14 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Portion of rent under operating leases representative of the interest component |
|
70 |
|
70 |
|
64 |
|
60 |
|
53 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
TOTAL FIXED CHARGES |
|
$ |
310 |
|
$ |
216 |
|
$ |
168 |
|
$ |
150 |
|
$ |
160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
RATIO OF EARNINGS TO FIXED CHARGES |
|
20.7 |
|
27.0 |
|
29.8 |
|
29.7 |
|
22.6 |
|
* 2007 results included pre-tax gains of $681 million, with net benefits from gains related to the sale of businesses and a gain on sale of real estate, which were partially offset by increases in environmental liabilities, restructuring actions, and other exit activities. 2006 results included pre-tax gains of $523 million, with net benefits from gains related to the sale of certain portions of 3Ms branded pharmaceuticals business partially offset by restructuring actions, acquired in-process research and development expenses, settlement costs of a previously disclosed antitrust class action, and environmental obligations related to the pharmaceuticals business. 2003 includes a $93 million pre-tax loss related to an adverse ruling associated with a lawsuit filed by LePages Inc.
3